TB Alliance to present research at ICAAC 2012
Workshop on Clinical Pharmacology of TB drugs to precede conference
The TB Alliance and its partners will be presenting recent advances in TB research and development at the ICAAC 2012 conference. Posters and presentations will detail important findings from the The University of Auckland and TB Alliance’s lead preclinical TB drug candidate, the nitroimidazole, TBA-354.
Read the full announcement here.
TB Alliance
